Aligos Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Aligos Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 12% to $15,529,000. The net income raised on -$87,679,000 and profit margin reached -565%. Total operating expenses were $103,656,000.
Profit Margin
| 2018 | 0 | -13.93M | |
|---|---|---|---|
| 2019 | 0 | -52.26M | |
| 2020 | 0 | -108.54M | |
| 2021 | 4.35M | -128.33M | -2944.07% |
| 2022 | 13.90M | -96.04M | -690.63% |
| 2023 | 15.52M | -87.67M | -564.61% |
ALGS Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 15.52M | 13.90M | 4.35M | 0 | 0 | 0 |
Cost of revenue | 3.06M | 3.67M | 104.15M | 3.32M | 2.29M | 0 |
Gross profit | 12.46M | 10.23M | -99.79M | -3.32M | -2.29M | 0 |
Operating exp. | ||||||
Research and development | 73.04M | 85.07M | 104.15M | 79.89M | 44.03M | 10.45M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 103.65M | 111.48M | 132.68M | 97.83M | 54.04M | 13.66M |
Operating income | -88.12M | -97.58M | -128.32M | -97.83M | -54.04M | -13.66M |
Other income (expenses), net | 1.24M | 1.64M | 132K | -10.54M | 1.86M | -435K |
Income before tax | -86.88M | -95.94M | -128.18M | -108.38M | -52.17M | -13.93M |
Income tax expense | 795K | 106K | 143K | 161K | 85K | -272K |
Net income | -87.67M | -96.04M | -128.33M | -108.54M | -52.26M | -13.93M |
Earnings per share | ||||||
Basic EPS | -3.52 | -2.25 | -3.22 | -3.18 | -2.38 | -0.66 |
Diluted EPS | -3.52 | -2.25 | -3.22 | -3.18 | -2.38 | -0.66 |
| Data source | Data source | Data source | Data source |